San Francisco / New York / Rehovot / Cambridge / /
Company
Takeda Pharmaceuticals / UBS / Idenix Pharmaceuticals / Biogen Idec / Stockholmbased Swedish Orphan Biovitrum / Merck / Pharmasset / Nature America Inc. / /
Continent
Asia / Europe / /
Country
Zimbabwe / Japan / United States / Afghanistan / Israel / /
Currency
USD / /
Event
M&A / FDA Phase / /
Facility
University of Manchester / Kyoto University / Weizmann Institute of Science / University College London Meera Paleja / University of Chile / University of California / McGill University / Royal Free Hospital / University School / /
IndustryTerm
technology development / brain networks / /
MedicalCondition
long-acting hemophilia B / ALS / hepatitis C / Obesity / abdominal pain / cancer / SARS / Crohn’s disease / HCV / ulcerative colitis / autoimmune disease / diseases / infection / infectious disease / anemia / severe hemophilia A / /
NaturalFeature
Mount Sinai / /
Organization
University of California / National Institute of Health / Kyoto University in Japan / University College London / Kavli Foundation / US government / Washington University School of Medicine in St. Louis / Institute for Health Metrics and Evaluation in Seattle / Shaw Prize Foundation in Hong Kong / Icahn School of Medicine / US Food and Drug Administration / University of Manchester / University of Chile in Santiago / Advisory Committee / Royal Free Hospital in London / McGill University in Montreal / Weizmann Institute of Science / /
Person
Richard Grencis / Brenda Milner / Eliav Barr / Marie Ng / Francis Collins / Nat / Marcus Raichle / Keith Gomez / Kazutoshi Mori / Claudio Hetz / Bruce Sands / Peter Walter / Marc Goodman / /
Position
global health researcher / principal investigator / parasitologist / neurologist / lead author / Study author / Director / biophysicist / biochemist / vice president of infectious disease research / analyst / /
NEWS IN BRIEF Biomedical briefing FUNDING npg